Posted by Michael Wonder on 08 Mar 2022
Saluda Medical receives FDA approval for the Evoke spinal cord stimulation system to treat chronic intractable pain
8 March 2022 - Evoke system deemed superior to open loop spinal cord stimulation in treating overall back and leg pain.
Saluda Medical today announced it received full approval from the U.S. FDA for the Evoke Spinal Cord Stimulation system.
The Evoke system is indicated for the treatment of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain.
